IP Library Granted Patent US 7,220,555
Granted Patent B2
US 7,220,555 · App. 10/081,455 · Granted May 22, 2007

Practical

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,220,555
App. No.
10/081,455
Granted
May 22, 2007
Kind
B2
Abstract

This invention provides methods for practical in vitro sialylation of glycoproteins, including recombinantly produced glycoproteins. The methods are useful for large-scale modification of sialylation patterns.

Claims (9)

1. A method of sialylating a saccharide group on a recombinant glycoprotein, the method comprising contacting a saccharide group which comprises a galactose or an N-acetylgalactosamine acceptor moiety on a recombinant glycoprotein with a sialic acid donor moiety and a Campylobacter jejuni α2,3-sialyltransferase in a reaction mixture which provides reactants required for sialyltransferase activity for a sufficient time and under appropriate conditions to transfer sialic acid from said sialic acid donor moiety to said saccharide group, wherein the concentration of sialyltransferase is at least 2 mUnit/mg of glycoprotein acceptor.

2. The method of claim 1 , wherein the α2,3-sialyltransferase is recombinant.

3. The method of claim 1 , wherein the α2,3-sialyltransferase is isolated.

4. The method of claim 1 , wherein the sialic acid donor moiety is CMP-sialic acid.

5. The method of claim 2 , wherein the CMP-sialic acid is enzyrnatically generated in situ.

6. The method of claim 1 , wherein the sialic acid is selected from the group consisting of NeuAc and NeuGe.

7. The method of claim 1 , wherein the concentration of sialyltransferase is less than 50 mUnits/mg of glycoprotein acceptor.

8. The method of claim 1 , wherein the glycoprotein concentrations are from 1–10 mg/ml.

9. The method of claim 1 , wherein the reaction mixture further comprises one or more additional recombinant or isolated sialyltransferases other than a α2,3-sialyltransferase.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 15, 2009
From: NEOSE TECHNOLOGIES, INC.
To: NOVO NORDISK A/S
Reel/Frame 022689/0733 →